Janus Henderson Group
RCKT icon

Janus Henderson Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Janus Henderson Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,253
Closed -$86.2K – 2454
2025
Q2 		$86.2K Sell
35,253
-3,255,590
-99% -$16.5M ﹤0.01% 2398
2025
Q1 		$25M Sell
3,290,843
-713,196
-18% -$7.05M 0.01% 520
2024
Q4 		$50.3M Buy
4,004,039
+2,106,699
+111% +$31.7M 0.03% 388
2024
Q3 		$35.1M Sell
1,897,340
-1,021,738
-35% -$20.9M 0.02% 461
2024
Q2 		$62.8M Buy
2,919,078
+313,062
+12% +$7.19M 0.03% 336
2024
Q1 		$70.2M Buy
2,606,016
+1,656,111
+174% +$47M 0.04% 323
2023
Q4 		$28.4M Buy
949,905
+47,810
+5% +$1.06M 0.02% 478
2023
Q3 		$18.5M Buy
902,095
+874,999
+3,229% +$15.9M 0.01% 548
2023
Q2 		$538K Buy
27,096
+66
+0.2% +$1.33K ﹤0.01% 1933
2023
Q1 		$463K Buy
27,030
+13,380
+98% +$262K ﹤0.01% 2064
2022
Q4 		$267K Buy
+13,650
New +$251K ﹤0.01% 2024
2022
Q1 		– Sell
-15,957
Closed -$348K – 2696
2021
Q4 		$348K Sell
15,957
-1,213,541
-99% -$33.1M ﹤0.01% 2119
2021
Q3 		$36.8M Sell
1,229,498
-5,991
-0.5% -$218K 0.02% 641
2021
Q2 		$54.7M Sell
1,235,489
-5,827
-0.5% -$253K 0.02% 547
2021
Q1 		$55.1M Sell
1,241,316
-35,994
-3% -$1.98M 0.03% 519
2020
Q4 		$70M Buy
1,277,310
+1,199,043
+1,532% +$43.7M 0.03% 458
2020
Q3 		$1.79M Buy
78,267
+4,698
+6% +$116K ﹤0.01% 1071
2020
Q2 		$1.54M Buy
73,569
+5,579
+8% +$101K ﹤0.01% 1066
2020
Q1 		$948K Buy
+67,990
New +$1.35M ﹤0.01% 1106

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Janus Henderson Group's RCKT Position: Q3 2025 in Review

Janus Henderson Group sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 35,253 shares — an estimated $86.2K sold.

Janus Henderson Group first reported a position in RCKT in Q1 2020 and held it in 19 quarters. The position peaked at $70.2M in Q1 2024. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Janus Henderson Group reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Janus Henderson Group sold 35,253 Rocket Pharmaceuticals shares in Q3 2025, an estimated $86.2K.
  • Janus Henderson Group first reported a position in Rocket Pharmaceuticals in Q1 2020 and held it in 19 quarters.
  • Janus Henderson Group's Rocket Pharmaceuticals position peaked at $70.2M in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.